MELPHALAN THERAPY IN MYELOMATOSIS

[1] ALWALL N, 1952, ACTA MED SCAND, V144, P114

[2] ALWALL N, 1947, Lancet, V2, P388

[3] CYTO-ACTIVE AMINO-ACID AND PEPTIDE DERIVATIVES .1. SUBSTITUTED PHENYLALANINES [J]. JOURNAL OF THE CHEMICAL SOCIETY, 1954, (JUL): : 2409 - 2417

[4] BERGSAGEL DE, 1962, CANC CHEMOTHER REP, V16, P261

[5] BERNARD J, 1962, NOUV REV FR HEMATOL, V2, P611

[6] CLINICAL EXPERIENCES WITH SARCOLYSIN IN NEOPLASTIC DISEASES [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 1128 - 1132

[7] HEREMANS JF, 1961, ACTA MED SCAND S367, V170

[8] LARIONOV LF, 1959, ACTA UNION INT CONTR, V15, P42

[9] TREATMENT OF MULTIPLE MYELOMA WITH URETHAN - EXPERIENCE WITH 66 CASES OVER A 2 112-YEAR PERIOD [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 147 (09): : 824 - 827

[10] MULTIPLE MYELOMA .3. EFFECT OF URETHANE THERAPY ON PLASMA CELL GROWTH, ABNORMAL SERUM PROTEIN COMPONENTS AND BENCE JONES PROTEINURIA [J]. JOURNAL OF CLINICAL INVESTIGATION, 1950, 29 (09) : 1243 - 1260

[1] ALWALL N, 1952, ACTA MED SCAND, V144, P114

[2] ALWALL N, 1947, Lancet, V2, P388

[3] CYTO-ACTIVE AMINO-ACID AND PEPTIDE DERIVATIVES .1. SUBSTITUTED PHENYLALANINES [J]. JOURNAL OF THE CHEMICAL SOCIETY, 1954, (JUL): : 2409 - 2417

[4] BERGSAGEL DE, 1962, CANC CHEMOTHER REP, V16, P261

[5] BERNARD J, 1962, NOUV REV FR HEMATOL, V2, P611

[6] CLINICAL EXPERIENCES WITH SARCOLYSIN IN NEOPLASTIC DISEASES [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 1128 - 1132

[7] HEREMANS JF, 1961, ACTA MED SCAND S367, V170

[8] LARIONOV LF, 1959, ACTA UNION INT CONTR, V15, P42

[9] TREATMENT OF MULTIPLE MYELOMA WITH URETHAN - EXPERIENCE WITH 66 CASES OVER A 2 112-YEAR PERIOD [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 147 (09): : 824 - 827

[10] MULTIPLE MYELOMA .3. EFFECT OF URETHANE THERAPY ON PLASMA CELL GROWTH, ABNORMAL SERUM PROTEIN COMPONENTS AND BENCE JONES PROTEINURIA [J]. JOURNAL OF CLINICAL INVESTIGATION, 1950, 29 (09) : 1243 - 1260